These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

930 related articles for article (PubMed ID: 24252944)

  • 1. Marginal pulmonary function should not preclude lobectomy in selected patients with non-small cell lung cancer.
    Taylor MD; LaPar DJ; Isbell JM; Kozower BD; Lau CL; Jones DR
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):738-44; Discussion 744-6. PubMed ID: 24252944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of stage I lung cancer in high-risk and inoperable patients: comparison of prospective clinical trials using stereotactic body radiotherapy (RTOG 0236), sublobar resection (ACOSOG Z4032), and radiofrequency ablation (ACOSOG Z4033).
    Crabtree T; Puri V; Timmerman R; Fernando H; Bradley J; Decker PA; Paulus R; Putnum JB; Dupuy DE; Meyers B
    J Thorac Cardiovasc Surg; 2013 Mar; 145(3):692-9. PubMed ID: 23174176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a patient-centered aggregate score to predict survival after lung resection for non-small cell lung cancer.
    Brunelli A; Salati M; Refai M; Xiumé F; Berardi R; Mazzanti P; Pompili C
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):385-90.e1-2. PubMed ID: 23651911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
    Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of lobectomy in patients with severely compromised lung function (predicted postoperative diffusing capacity of the lung for carbon monoxide % ≤ 40%).
    Paul S; Andrews WG; Nasar A; Port JL; Lee PC; Stiles BM; Altorki NK
    Ann Am Thorac Soc; 2013 Dec; 10(6):616-21. PubMed ID: 24015712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of tumor size on outcomes after anatomic lung resection for stage 1A non-small cell lung cancer based on the current staging system.
    Carr SR; Schuchert MJ; Pennathur A; Wilson DO; Siegfried JM; Luketich JD; Landreneau RJ
    J Thorac Cardiovasc Surg; 2012 Feb; 143(2):390-7. PubMed ID: 22169444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of preoperative body mass index on respiratory complications after pneumonectomy for non-small-cell lung cancer. Results from a series of 154 consecutive standard pneumonectomies.
    Petrella F; Radice D; Borri A; Galetta D; Gasparri R; Solli P; Veronesi G; Spaggiari L
    Eur J Cardiothorac Surg; 2011 May; 39(5):738-44. PubMed ID: 20952203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term survival after lobectomy for non-small cell lung cancer by video-assisted thoracic surgery versus thoracotomy.
    Lee PC; Nasar A; Port JL; Paul S; Stiles B; Chiu YL; Andrews WG; Altorki NK
    Ann Thorac Surg; 2013 Sep; 96(3):951-60; discussion 960-1. PubMed ID: 23866808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of survival after sublobar resections and ablative therapies for stage I non-small cell lung cancer.
    Zemlyak A; Moore WH; Bilfinger TV
    J Am Coll Surg; 2010 Jul; 211(1):68-72. PubMed ID: 20610251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Robotic lobectomy for non-small cell lung cancer (NSCLC): long-term oncologic results.
    Park BJ; Melfi F; Mussi A; Maisonneuve P; Spaggiari L; Da Silva RK; Veronesi G
    J Thorac Cardiovasc Surg; 2012 Feb; 143(2):383-9. PubMed ID: 22104677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary function and quality of life after VMAT-based stereotactic ablative radiotherapy for early stage inoperable NSCLC: a prospective study.
    Ferrero C; Badellino S; Filippi AR; Focaraccio L; Giaj Levra M; Levis M; Moretto F; Torchio R; Ricardi U; Novello S
    Lung Cancer; 2015 Sep; 89(3):350-6. PubMed ID: 26164208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A national study of nodal upstaging after thoracoscopic versus open lobectomy for clinical stage I lung cancer.
    Licht PB; Jørgensen OD; Ladegaard L; Jakobsen E
    Ann Thorac Surg; 2013 Sep; 96(3):943-9; discussion 949-50. PubMed ID: 23684159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative Pulmonary Function Tests (PFTs) and Outcomes from Resected Early Stage Non-small Cell Lung Cancer (NSCLC).
    Almquist D; Khanal N; Smith L; Ganti AK
    Anticancer Res; 2018 May; 38(5):2903-2907. PubMed ID: 29715115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thoracoscopic lobectomy is associated with acceptable morbidity and mortality in patients with predicted postoperative forced expiratory volume in 1 second or diffusing capacity for carbon monoxide less than 40% of normal.
    Burt BM; Kosinski AS; Shrager JB; Onaitis MW; Weigel T
    J Thorac Cardiovasc Surg; 2014 Jul; 148(1):19-28, dicussion 28-29.e1. PubMed ID: 24766848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis.
    El-Sherif A; Gooding WE; Santos R; Pettiford B; Ferson PF; Fernando HC; Urda SJ; Luketich JD; Landreneau RJ
    Ann Thorac Surg; 2006 Aug; 82(2):408-15; discussion 415-6. PubMed ID: 16863738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thermal ablation matches sublobar resection outcomes in older patients with early-stage non-small cell lung cancer.
    Kwan SW; Mortell KE; Talenfeld AD; Brunner MC
    J Vasc Interv Radiol; 2014 Jan; 25(1):1-9.e1. PubMed ID: 24365502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ["Intentionally" limited pulmonary resection versus lobectomy for the treatment of peripheral stage IA non-small cell lung cancers].
    Mondello B; Sibilio M; Pavone A; Monaco F; Nunnari F; Micali V; Vasta I; Perrone O; Monaco M
    G Chir; 2007; 28(1-2):7-12. PubMed ID: 17313726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The National Surgical Quality Improvement Program risk calculator does not adequately stratify risk for patients with clinical stage I non-small cell lung cancer.
    Samson P; Robinson CG; Bradley J; Lee A; Broderick S; Kreisel D; Krupnick AS; Patterson GA; Puri V; Meyers BF; Crabtree T
    J Thorac Cardiovasc Surg; 2016 Mar; 151(3):697-705.e1. PubMed ID: 26410001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules.
    Altorki NK; Yip R; Hanaoka T; Bauer T; Aye R; Kohman L; Sheppard B; Thurer R; Andaz S; Smith M; Mayfield W; Grannis F; Korst R; Pass H; Straznicka M; Flores R; Henschke CI;
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):754-62; Discussion 762-4. PubMed ID: 24280722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Segmental resection spares pulmonary function in patients with stage I lung cancer.
    Keenan RJ; Landreneau RJ; Maley RH; Singh D; Macherey R; Bartley S; Santucci T
    Ann Thorac Surg; 2004 Jul; 78(1):228-33; discussion 228-33. PubMed ID: 15223434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.